The CommonHealth

How do we explain the peril that global health faces? Covid and the post-Covid backlash. The Biden years’ “status quo” approach. Less support in Europe. Excessive debt in Africa. The generational shift in Congress and aging of the flagship programs: “Time has passed.” “We never really dealt with PEPFAR’s treatment mortgage.” Dealing with the conservative critique of US global health funding Is essential to revitalize bipartisanship. 2025 could be rocky, should resources shrink. “We need to be creative, and realistic.” What should we make of the emerging Trump leadership team, most significantly, Senator Rubio, Elise Stefanik, RFK Jr., and Jay Bhattacharya?

In the sixth episode of the CommonHealth Live! series, Katherine E. Bliss will sit down with Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean. Dr. Balkhy will speak to her evolving vision for the region, encompassing EMRO’s multiple complex humanitarian operations—in Gaza, Yemen, Afghanistan, Libya, and beyond. She will also reflect on the growing challenge of antimicrobial resistance and what may come out of the UN High-Level Meeting on Antimicrobial Resistance (AMR) to be held on the margins of the UN General Assembly on September 26.

This event is made possible through the generous support of the Bill & Melinda Gates Foundation. 

In the seventh episode of the CommonHealth Live! series, Katherine E. Bliss will sit down with Dr. John Balbus, Director of the Office of Climate Change and Health Equity at the U.S. Department of Health and Human Services. Dr. Balbus will speak about the foundation of his office in 2021, the work it has engaged in so far, lessons learned, and his vision for the future. 

This event is made possible by the generous support of the Wellcome Trust and GSK​​​

Javier Guzman, Center for Global Development debriefs on the High Level Meeting on Anti-Microbial Resistance held in New York City on September 26. Successes took several forms: significant new data, analyses, and projections; a political declaration committed to the creation of a scientific panel; elevation of equity of access and accountability; a target to reduce deaths by 10% by 2030; and agreement to convene again in 5 years. The panel has to be seen as a joint enterprise between the north and south. Emerging economies are getting more engaged. There are serious reservations among many countries that are heavily dependent on animal production. We do not have much visibility into what is happening in China. Data remains elusive. The $100m target of national governments commitment is “a drop in the ocean.” There is an urgent need for creative, large-scale financing and plans to bring to scale access to AMR technology. Countries themselves have to take control and commit. 

Dr. Michael Osterholm unpacks the history of H5N1, as we struggle with the question of whether the current H5N1 outbreak may pose a grave threat of a human-to-human pandemic. "It’s possible that H5N1 may never get over the bar for human disease and we don’t know why.” He also speaks to what we are likely to face in the months ahead from the mpox clade 1b outbreak, centered in Africa. 

Nidhi Bouri, DAA at USAID Bureau for Global Health, joined us to speak to the U.S. response to the dangerous mpox outbreak (clade 1b) centered in the Democratic Republic of Congo, boosted by President Biden’s commitment at UNGA to $500m in support, including 1 million vaccine doses. Much better data is urgently needed on the needs for diagnostics and vaccines. Tensions remain high among Africa CDC, WHO, and other key institutions with proven response capability, most notably Gavi, UNICEF and the Global Fund. Much is not known about modes of transmission, and the durability and efficacy of the Jynneos vaccine for clade 1b. As the virus inevitably lands in the United States, communications will be critical. Some important progress was seen in the High Level Meeting on anti-microbial resistance. The Marburg outbreak in Rwanda is of acute concern for multiple reasons: no vaccine, little testing, little knowledge of the pattern of spread. It is crunch time, as multiple replenishments converge. “Let’s be clear, there is not enough money.”

Dr. Jerome Adams authored his 2023 memoire, Crisis and Chaos: Lessons from the Front Lines of the War Against COVID-19. In it, he reflects on his upbringing in southern Maryland and the acute “hurting” among many citizens, rural and poor, dissatisfied with the status quo. Profoundly impactful to his tenure as Indiana State Health Commissioner was managing the opioid, Hepatitis C, and HIV outbreaks in Scott County, IN. As U.S. Surgeon General, he carried forward his enduring commitment to the overdose reversal drug, naloxone. During Covid, politics and toxic partisanship severely hampered the US response. “We keep playing whack-a-mole.” Upgraded communications were urgently needed. The attacks from within the Trump White House upon Dr. Fauci were paralleled by attacks on public health officials at state and local levels. Give a listen to learn more. 

Dr. Anthony Fauci sat down with J. Stephen Morrison, CSIS, on August 13, for a conversation on his remarkable 54 year career of service as a doctor and scientist. Listen to hear about his early upbringing in Bensonhurst, Brooklyn; his Jesuit training; his expansive leadership at NIH on HIV/AIDS in the darkest days; the creation of a position of influence in science and public health unprecedented in American history, tied to the trust and confidence of six presidents; and, of course, his confrontation with President Trump during Covid and Trump’s campaign to discredit and damage him.

Dr. Megan Ranney, the dynamic, charismatic Dean of the Yale School of Public Health, joined us to illuminate the strategy she has pioneered to curb firearm injuries and deaths in America. It is a true epidemic that begs a serious public health approach. It requires coming to terms with suicide and homicide in America—both sensitive, disturbing phenomena. It requires a concentrated focus on data gaps, research investments, effective interventions, and scaling the response. Together these actions hold the promise of reducing deaths and injuries by 50 percent. Many commonsense actions are steadily achieving major gains, including safe storage of weapons, better engineering of weapons, fostering a community of dedicated researchers, and introducing economic incentives that favor safety. In combination, these are demonstrably raising hope, even in the face of enduring stigma and skepticism, political divisions, gaps in knowledge, and misinformation and disinformation. Come listen for the full story. 

Please note this episode contains subject matter relating to gun violence and the topic of suicide. Listener discretion is advised.

With the International AIDS Society’s 25th global conference taking place next week in Munich, Mark Lagon, Chief Policy Officer at Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria and Bennett Freeman, Associate Fellow with Chatham House, joined Katherine to discuss a new Friends report regarding the role of the private sector and civil society organizations in advocating for global health programs, including HIV services. Lagon and Freeman argue that in a period during which restrictions on civic space seem to be increasing in many countries around the world, there is a business case to be made for the private sector in defending civil society organizations’ efforts to promote respect for human rights, monitor for equitable access to services, and encourage transparency and accountability within global health programs and beyond.